Publication: OncLive
In an exclusive podcast interview with OncLive On Air™, Vijay Gunuganti, M.D., hematologist and medical oncologist at Texas Oncology–San Antonio Northeast, discusses current frontline treatment options in advanced, driver-negative non–small cell lung cancer. He also details the patient selection process for frontline immunotherapy, combination immunotherapy, and chemoimmunotherapy in non-small cell lung cancer.
Listen to the podcast and view the full story at OncLive.